Original Research

HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: A prospective study

Jade C. Mogambery, Halima Dawood, Douglas Wilson, Anand Moodley
Southern African Journal of HIV Medicine | Vol 18, No 1 | a732 | DOI: https://doi.org/10.4102/sajhivmed.v18i1.732 | © 2017 Jade C. Mogambery, Halima Dawood, Douglas Wilson, Anand Moodley | This work is licensed under CC Attribution 4.0
Submitted: 27 January 2017 | Published: 26 September 2017

About the author(s)

Jade C. Mogambery, Department of Internal Medicine, Ngwelezana Hospital, University of KwaZulu-Natal, South Africa
Halima Dawood, Department of Internal Medicine, Infectious Diseases Unit, Grey’s Hospital, University of KwaZulu-Natal, South Africa
Douglas Wilson, Department of Internal Medicine, Edendale Hospital, University of KwaZulu-Natal, South Africa
Anand Moodley, Department of Neurology, Grey’s Hospital, University of KwaZulu-Natal, South Africa

Abstract

Introduction: HIV-associated neurocognitive disorder (HAND) is a consequence of HIV infection of the central nervous system. The prevalence ranges between 15% and 60% in different settings.

Objectives: This prospective study determined the prevalence of HAND at a peri-urban HIV clinic in KwaZulu-Natal. Factors associated with HAND were examined, alternate neurocognitive tools were tested against the international HIV dementia scale (IHDS) score and an association between HAND and non-adherence to antiretroviral therapy (ART) was explored.

Methods: Between May 2014 and May 2015, 146 ART-naïve outpatients were assessed for HAND. IHDS score ≤ 10 established a diagnosis of HAND. Functional capacity was assessed using Eastern Cooperative Oncology Group (ECOG) score. Chi-squared test was used to identify risk factors for HAND. The get-up-and-go test (GUGT) and Center for Epidemiological Studies Depression scale – revised (CESD-r) were tested against the IHDS. HIV viral load done six months after initiating ART was used as a surrogate marker for adherence to ART.

Results: The prevalence of HAND was 53%. In total, 99.9% of patients with HAND had no functional impairment. Age > 50 years old was associated with HAND (p = 0.003). There was no correlation between the GUGT, CESD-r and the IHDS score. HAND was not associated with non-adherence (p = 0.06).

Conclusions: While the prevalence of HAND is high, it is not associated with functional impairment which suggests that asymptomatic neurocognitive impairment is prevalent. Age > 50 years old is a risk factor for HAND. The GUGT and CESD-r are not useful diagnostic tools for HAND. The relationship between HAND and non-adherence should be further explored.


Keywords

No related keywords in the metadata.

Metrics

Total abstract views: 4548
Total article views: 7188

 

Crossref Citations

1. A multidisciplinary approach for people with HIV failing antiretroviral therapy in South Africa
Parisha M. Juta, Juan M. Jansen van Vuuren, Kabamba J. Mbaya
Southern African Journal of HIV Medicine  vol: 25  issue: 1  year: 2024  
doi: 10.4102/sajhivmed.v25i1.1579

2. Cognitive impairment and its associated factors among HIV/AIDS patients on anti retro -viral therapy in Sub-Saharan Africa: Systematic review and meta-analysis
Getachew Yideg Yitbarek, Gashaw Walle Ayehu, Belete Achamyelew Ayele, Wubet Alebachew Bayih, Alemayehu Digssie Gebremariam, Sofonyas Abebaw Tiruneh
Neurology, Psychiatry and Brain Research  vol: 38  first page: 83  year: 2020  
doi: 10.1016/j.npbr.2020.11.002

3. Meta-analysis of factors affecting prevalence estimates of HIV-associated neurocognitive disorder in sub-Saharan Africa
Martins C. Nweke, Adaora J. Okemuo, Ekezie M. Uduonu, Princewill I. Ugwu, Chioma Nwachukwu, Nombeko Mshunqane
South African Journal of Science  vol: 117  issue: 9/10  year: 2021  
doi: 10.17159/sajs.2021/8575

4. Coping in crisis: The role of sense of coherence, life satisfaction, and resilience in the relationship between depression, social support, fear of COVID-19, and perceived vulnerability to disease among nurses in South Africa
Bronwyne Coetzee, Phillipa Haine, Martin Kidd, Lindokuhle Shongwe, Marnus Janse Van Vuuren, Ashraf Kagee
Journal of Health Psychology  vol: 30  issue: 10  first page: 2542  year: 2025  
doi: 10.1177/13591053241279000

5. Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments
Monray E. Williams, Simo S. Zulu, Dan J. Stein, John A. Joska, Petrus J.W. Naudé
Neurobiology of Disease  vol: 136  first page: 104701  year: 2020  
doi: 10.1016/j.nbd.2019.104701

6. An Overview of HIV-associated Neurocognitive Disorder in South Africa
Brian Thabile Flepisi, Marissa Balmith
Current Behavioral Neuroscience Reports  vol: 12  issue: 1  year: 2025  
doi: 10.1007/s40473-025-00298-x

7. Functioning Problems Associated with Health Conditions with Greatest Disease Burden in South Africa: A Scoping Review
Maria Y. Charumbira, Karina Berner, Quinette A. Louw
International Journal of Environmental Research and Public Health  vol: 19  issue: 23  first page: 15636  year: 2022  
doi: 10.3390/ijerph192315636

8. Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics
Ian Simon Olivier, Ramón Cacabelos, Vinogran Naidoo
International Journal of Molecular Sciences  vol: 19  issue: 11  first page: 3594  year: 2018  
doi: 10.3390/ijms19113594

9. Prevalence and variability of HIV/AIDS-associated neurocognitive impairments in Africa: a systematic review and meta-analysis
Birhanie Mekuriaw, Zelalem Belayneh, Worku Teshome, Yonas Akalu
BMC Public Health  vol: 23  issue: 1  year: 2023  
doi: 10.1186/s12889-023-15935-x

10. Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda
Ned Sacktor, Deanna Saylor, Gertrude Nakigozi, Noeline Nakasujja, Kevin Robertson, M. Kate Grabowski, Alice Kisakye, James Batte, Richard Mayanja, Aggrey Anok, Ronald H. Gray, Maria J. Wawer
JAIDS Journal of Acquired Immune Deficiency Syndromes  vol: 81  issue: 2  first page: 216  year: 2019  
doi: 10.1097/QAI.0000000000001992

11. Cognitive differences associated with HIV serostatus and antiretroviral therapy use in a population-based sample of older adults in South Africa
Stephen B. Asiimwe, Meagan Farrell, Lindsay C. Kobayashi, Jen Manne-Goehler, Kathleen Kahn, Stephen M. Tollman, Chodziwadziwa Whiteson Kabudula, F. Xavier Gómez-Olivé, Ryan G. Wagner, Livia Montana, Lisa F. Berkman, M. Maria Glymour, Till Bärnighausen
Scientific Reports  vol: 10  issue: 1  year: 2020  
doi: 10.1038/s41598-020-73689-7

12. Attention/Working Memory, Learning and Memory in Adult Cameroonians: Normative Data, Effects of HIV Infection and Viral Genotype
Georgette D. Kanmogne, Julius Y. Fonsah, Anya Umlauf, Jacob Moul, Roland F. Doh, Anne M. Kengne, Bin Tang, Claude T. Tagny, Emilienne Nchindap, Léopoldine Kenmogne, Donald Franklin, Dora M. Njamnshi, Dora Mbanya, Alfred K. Njamnshi, Robert K. Heaton
Journal of the International Neuropsychological Society  vol: 26  issue: 6  first page: 607  year: 2020  
doi: 10.1017/S1355617720000120

13. Relationship between High Sensitivity-C Reactive Protein Level and Impaired Cognitive Function in HIV Patients
Rachmi Kurniawati, PAULUS SUGIANTO
Folia Medica Indonesiana  vol: 57  issue: 1  first page: 63  year: 2021  
doi: 10.20473/fmi.v57i1.16733